Xi'an International Medical Investment Yönetim

Yönetim kriter kontrolleri 4/4

Xi'an International Medical Investment CEO'su Ruixuan Liu, May2021 tarihinde atandı, in görev süresi 3.5 yıldır. şirketin hisselerinin 0.043% doğrudan sahiptir ve bu hisselerin değeri CN¥ 5.82M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.5 yıl ve 3.5 yıldır.

Anahtar bilgiler

Ruixuan Liu

İcra Kurulu Başkanı

CN¥600.0k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	3.5yrs
CEO sahipliği	0.04%
Yönetim ortalama görev süresi	3.5yrs
Yönetim Kurulu ortalama görev süresi	3.5yrs

Son yönetim güncellemeleri

Recent updates

After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Oct 01

Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Jul 16

Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Jun 20

Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Mar 25

Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

Feb 28

CEO

Ruixuan Liu (55 yo)

3.5yrs

Görev süresi

CN¥600,000

Tazminat

Mr. Ruixuan Liu has been Vice President and Financial Controller of XKHG since 2005. Mr. Liu served as Vice President of Xi'an International Medical Investment Company Limited. Mr. Liu worked in Xi’an Mins...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Ruixuan Liu	President & Director	3.5yrs	CN¥600.00k	0.043% CN¥ 5.8m
Yaxing Wang	Financial Director	3.5yrs	CN¥450.00k	0.0071% CN¥ 957.1k
Wen Guo Sun	VP & Director	3.5yrs	CN¥450.00k	0.015% CN¥ 2.0m
Zhen Ding	VP & Board Secretary	no data	CN¥450.00k	0.0069% CN¥ 930.3k
Gao Wang	Vice President	no data	CN¥450.00k	0.0071% CN¥ 957.1k
Yikuan Sun	Vice President	no data	CN¥450.00k	0.0053% CN¥ 714.5k
Ziqi Wei	Head of Accounting	no data	Veri yok	Veri yok

3.5yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim: 000516 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Ruixuan Liu	President & Director	3.5yrs	CN¥600.00k	0.043% CN¥ 5.8m
Wen Guo Sun	VP & Director	3.5yrs	CN¥450.00k	0.015% CN¥ 2.0m
He Ling Cao	Vice Chairman	3.5yrs	CN¥500.00k	1.87% CN¥ 250.5m
Aiping Wang	Vice-Chairman of the Board of Directors	3.5yrs	CN¥600.00k	0.012% CN¥ 1.6m
Ping Shi	Independent Director	3.5yrs	CN¥80.00k	Veri yok
Xu Liu	Vice Chairman	3.5yrs	CN¥450.00k	Veri yok
Yong Liu	Member of the Supervisory Board	3.5yrs	Veri yok	Veri yok
Kai Li	Member of the Supervisory Board	3.5yrs	Veri yok	Veri yok
Jin Shi	Chairman of the Board of Directors	3.5yrs	CN¥700.00k	0.021% CN¥ 2.8m
Jian An Cao	Chairman of the Supervisory Board	3.5yrs	Veri yok	Veri yok
Bao Tong Zhang	Independent Director	3.5yrs	CN¥80.00k	Veri yok
Fu Li	Independent Director	3.5yrs	CN¥80.00k	Veri yok

3.5yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 000516 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.5 yıldır).

Xi'an International Medical Investment Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Xi'an International Medical Investment Company Limited, Annual General Meeting, May 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: CN¥0.018 loss per share (vs CN¥0 in 3Q 2023)

After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Xi'an International Medical Investment Company Limited to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released: CN¥0.03 loss per share (vs CN¥0.065 loss in 2Q 2023)

Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Xi'an International Medical Investment Company Limited to Report First Half, 2024 Results on Aug 28, 2024

Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Xi'an International Medical Investment Company Limited (SZSE:000516) commences an Equity Buyback Plan for CNY 150 million worth of its shares, under the authorization approved on May 20, 2024.

Xi'an International Medical Investment Company Limited, Annual General Meeting, May 20, 2024

First quarter 2024 earnings released: CN¥0.046 loss per share (vs CN¥0.033 loss in 1Q 2023)

Xi'an International Medical Investment Company Limited to Report Q1, 2024 Results on Apr 26, 2024

Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

Xi'an International Medical Investment Company Limited to Report Fiscal Year 2023 Results on Apr 26, 2024

Xi'an International Medical Investment Company Limited(SZSE:000516) dropped from Shenzhen Stock Exchange Component A Share Index

Third quarter 2023 earnings released: EPS: CN¥0 (vs CN¥0.10 loss in 3Q 2022)

Xi'an International Medical Investment Company Limited to Report Q3, 2023 Results on Oct 27, 2023

Second quarter 2023 earnings released: CN¥0.065 loss per share (vs CN¥0.074 loss in 2Q 2022)

Now 21% undervalued after recent price drop

First quarter 2023 earnings released: CN¥0.033 loss per share (vs CN¥0.19 loss in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.10 loss per share (vs CN¥0.099 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.074 loss per share (vs CN¥0.072 loss in 2Q 2021)

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Xi'an International Medical Investment Company Limited(SZSE:000516) dropped from Shenzhen Stock Exchange Component Index

Xi'an International Medical Investment Company Limited(XSEC:000516) dropped from FTSE All-World Index (USD)

Third quarter 2021 earnings released: CN¥0.099 loss per share (vs CN¥0.08 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.072 loss per share (vs CN¥0.079 loss in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.03 (vs CN¥0.21 loss in FY 2019)

New 90-day high: CN¥13.03

New 90-day high: CN¥9.25

New 90-day high: CN¥8.60

Third quarter earnings released

New 90-day high: CN¥7.87

New 90-day high: CN¥7.52

New 90-day high: CN¥7.04

First half earnings released

Xi'an International Medical Investment Company Limited to Report First Half, 2020 Results on Aug 28, 2020

Xi'an International Medical Investment Company Limited announced that it expects to receive CNY 1 billion in funding from Shaanxi Century Xinyuan Commercial Management Co., Ltd.

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş